Skip to main content

Table 1 Clinical characteristics for all patients who underwent radical prostatectomy

From: Effects of surgeon variability on oncologic and functional outcomes in a population-based setting

  

All patients N = 1,280

Age at surgery, median years (IQR)

 

64

(60,67)

PSA at diagnosis, median (IQR) ng/mL (Missing n=3)

 

6.3

(4.5,9.8)

Follow-up for biochemical recurrence, median years (IQR)

 

5.28

(3.59-6.83)

  

n

(%)

Pathological Gleason score (Missing n=2)

≤ 6

593

(46.5)

 

7

624

(48.9)

 

≥ 8

59

(4.6)

 

No tumor found

2

-

Nerve-sparing surgery (Missing n=3)

No

625

(48.9)

 

Unilateral

196

(15.3)

 

Bilateral

456

(35.7)

Surgical margins (Missing n=5)

Positive

333

(26.1)

 

Negative

942

(73.9)

Seminal vesicle invasion (Missing n=16)

Yes

109

(8.6)

 

No

1155

(91.4)

Pathological stage (Missing n=7)

pT0

2

(0.2)

 

pT2

906

(71.2)

 

pT3

365

(28.7)

Preoperative erectile function (Missing n=241)

Potent

679

(65.4)

 

Impotent

360

(34.7)

Postoperative erectile function at 18 months (Missing n=633)

Potent

122

(18.9)

 

Impotent

525

(81.1)

Preoperative urinary function (Missing n=202)

Continent

1053

(97.7)

 

Incontinent

25

(2.3)

Postoperative urinary function at 18 months (Missing n=301)

Continent

836

(85.4)

 

Incontinent

143

(14.6)

  1. PSA = prostate-specific antigen, IQR = Inter Quartile Range.